info icon

This is a non-core endpoint: only basic statistics are computed.

Malignant neoplasm of retroperitoneum and peritoneum

C3_RETROPERITONEUM_PERITONEUM

retroperitoneal cancer: An organ system cancer located_in the retroperitoneal space that is manifested in retroperitoneal space in the abdominal cavity behind the peritoneum.

Suggest a new description

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 C48
  • Cancer registry: Topography ICD-O-3 C48
  • Cancer registry: Morphology ICD-O-3 ANY
  • Cancer registry: Behaviour codes 3

2 out of 7 registries used, show all original rules.

300

4. Check minimum number of events

None

300

5. Include endpoints

None

300

6. Filter based on genotype QC (FinnGen only)

281

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 281 200 81
Unadjusted period prevalence (%) 0.06 0.07 0.04
Median age at first event (years) 68.03 67.64 69.00

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
289
Matched controls
2890
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
203.9
307.7
166
19
WX302
NOMESCO Finland
Thoracal epidural anesthesy
106.6
244.6
130
22
A04AA01
ATC
ondansetron; systemic, rectal
55.2
208.1
128
41
A03FA01
ATC
metoclopramide; systemic, rectal
27.4
188.0
206
240
Z51.5
ICD-10 Finland
Palliative care
34.7
168.5
120
58
130
Kela drug reimbursment
Malignant tumour
+∞
155.7
135
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
25.2
143.4
117
76
R18
ICD-10 Finland
Ascites
78.1
130.3
71
12
JN4BD
NOMESCO Finland
Extensive body CT
25.5
125.5
98
57
JN4AD
NOMESCO Finland
Body CT examination
19.9
113.5
101
76
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
94.0
85
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
89.3
81
*
B01AB10
ATC
tinzaparin; parenteral
11.8
83.8
106
135
N02AA05
ATC
oxycodone; systemic
9.5
83.1
151
299
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
+∞
82.3
75
*
L03AA13
ATC
pegfilgrastim; parenteral
502.2
77.8
74
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
19.8
76.7
64
41
JAL30
NOMESCO Finland
Omentectomy
167.9
74.0
75
6
WW500
NOMESCO Finland
Blood transfusion
30.0
72.8
50
20
128
Kela drug reimbursment
Cancers of female genital organs
+∞
69.7
64
*
8461/3-C48.2
ICD-O-3
High grade serous carcinoma of peritoneum, NOS
+∞
68.5
63
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
38.7
68.2
43
13
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
65.1
60
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
64.0
59
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
62.8
58
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.5
57.4
59
54
L03AA02
ATC
filgrastim; parenteral
+∞
57.2
53
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
22.8
56.6
43
22
TPH07
NOMESCO Finland
Cathetrisation of artery
7.9
55.8
96
171
JAH00
NOMESCO Finland
Laparotomy
18.2
53.2
45
29
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
52.7
49
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
51.6
48
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
51.6
48
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
18.9
49.7
41
25
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
48.3
45
*
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
46.1
43
*
WX402
NOMESCO Finland
General anaesthesia
5.8
45.6
119
312
A04AA55
ATC
palonosetron, combinations; systemic
+∞
43.9
41
*
L02BG04
ATC
letrozole; oral
92.8
43.4
47
6
JN3AD
NOMESCO Finland
Abdominal CT examination
6.4
42.6
88
185
LCD00
NOMESCO Finland
Hysterectomy
9.4
41.0
54
69
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
444.8
40.1
39
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
64.5
38.6
44
8
C48.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of retroperitoneum and peritoneum
+∞
38.4
36
*
B01AB05
ATC
enoxaparin; parenteral
4.6
36.9
159
607
JEA00
NOMESCO Finland
Appendectomy
9.0
36.9
50
66
XX3DW
NOMESCO Finland
Time consuming IT work
8.9
35.5
48
63
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.2
35.5
72
147
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
35.1
33
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
34.0
32
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
132.2
33.5
35
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
32.9
31
*
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
127.9
32.4
34
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
31.9
30
*
ZX120
NOMESCO Finland
Intravenous
7.3
31.6
51
82
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
348.7
31.5
31
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
9.6
31.2
39
46
WZC00
NOMESCO Finland
Treatment plan or consultation
4.1
31.1
141
544
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
30.8
29
*
JAH01
NOMESCO Finland
Laparoscopy
9.1
30.6
40
50
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
335.6
30.4
30
*
ZXE20
NOMESCO Finland
More than three and less than five hours
5.0
29.1
77
197
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
107.1
27.2
29
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
26.5
25
*
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
26.5
25
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.9
25.8
68
172
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.0
24.7
90
291
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
25.5
24.5
34
15
8858/3-C48.0
ICD-O-3
Dedifferentiated liposarcoma of retroperitoneum
+∞
24.3
23
*
A79
ICPC
Malignancy NOS
+∞
24.3
23
*
A04AD12
ATC
aprepitant; systemic
+∞
24.3
23
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
24.3
23
*
8461/3-C48.1
ICD-O-3
High grade serous carcinoma of specified parts of peritoneum
+∞
24.3
23
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
24.3
23
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
136.3
24.0
25
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
23.2
22
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
65.1
21.2
24
*
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
+∞
21.1
20
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
21.1
20
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.4
20.4
101
394
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
8.3
20.3
28
37
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
20.3
58
155
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
+∞
20.0
19
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
20.0
19
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
112.8
19.8
21
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
19.7
78
263
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
22.0
19.5
28
14
WZC30
NOMESCO Finland
Teaching
4.0
19.5
66
200
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
19.0
18
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
202.6
18.8
19
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
202.6
18.8
19
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
18.3
183
1051
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.2
18.2
33
59
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
19.7
18.2
27
15
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
17.9
17
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
17.9
17
*
KAC00
NOMESCO Finland
Nephrectomy
+∞
17.9
17
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
17.9
17
*
8890/3-C48.0
ICD-O-3
Leiomyosarcoma, NOS, of retroperitoneum
+∞
17.9
17
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.9
17.8
34
64
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
17.2
89
353
WF002
NOMESCO Finland
Radical radiotherapy
67.5
16.9
19
*
8850/3-C48.0
ICD-O-3
Liposarcoma, NOS, of retroperitoneum
+∞
16.8
16
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
16.8
16
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
16.8
16
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
+∞
16.8
16
*
JFB00
NOMESCO Finland
Partial resection of small intestine
42.8
16.6
20
5
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
12.8
16.5
29
25
JN4CD
NOMESCO Finland
Very extensive body CT
20.0
16.3
24
13
A06AH03
ATC
naloxegol; oral
50.6
16.2
19
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
18.6
15.9
24
14
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
+∞
15.8
15
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
12.3
15.1
27
24
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
26.7
14.9
20
8
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
14.7
14
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
14.7
14
*
C48.2
ICD-10 Finland
Malignant neoplasm: Peritoneum, unspecified
+∞
14.7
14
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
13.6
14.7
25
20
Z31.5
ICD-10 Finland
Genetic counselling
6.9
14.3
23
36
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.8
14.0
47
140
JFB30
NOMESCO Finland
Right hemicolectomy
56.2
14.0
16
*
B01AB04
ATC
dalteparin; parenteral
5.6
13.7
27
52
HA1AA
NOMESCO Finland
X-ray mammography
5.6
13.7
27
52
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
79.0
13.7
15
*
C48.29
ICD-10 Finland
Malignant tumor in unspecified localization in peritoneum other or unspecified histology
+∞
13.6
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.6
13
*
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
146.6
13.6
14
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.7
13.0
98
468
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
12.6
12
*
115
Kela drug reimbursment
Breast cancer
+∞
12.6
12
*
389
Kela drug reimbursment
Olaparib
+∞
12.6
12
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
12.6
12
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
+∞
12.6
12
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
12.6
12
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
+∞
12.6
12
*
L02BA01
ATC
tamoxifen; oral
+∞
12.6
12
*
3009
Kela drug reimbursment
Niraparib
+∞
12.6
12
*
X77
ICPC
Malignant neopl genital female other
+∞
12.6
12
*
1510
Kela drug reimbursment
Niraparib
+∞
12.6
12
*
9050/3-C48.2
ICD-O-3
Mesothelioma, malignant of peritoneum, NOS
+∞
12.6
12
*
159
Kela drug reimbursment
Pazopanib
+∞
12.6
12
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
12.6
12
*
1511
Kela drug reimbursment
Olaparib
+∞
12.6
12
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
12.6
12
*
C48.20
ICD-10 Finland
Malignant tumor in unspecified localization in the peritoneum without histology
+∞
12.6
12
*
9680/3-C48.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of retroperitoneum
+∞
12.6
12
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
12.6
12
*
L01XK02
ATC
niraparib; oral
+∞
12.6
12
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
135.7
12.5
13
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.4
12.0
131
738
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.3
11.9
25
51
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
11.7
122
671
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
11.5
11
*
JFF10
NOMESCO Finland
Loop enterostomy
+∞
11.5
11
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
11.5
11
*
C48.1
ICD-10 Finland
Malignant neoplasm: Specified parts of peritoneum
+∞
11.5
11
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
11.5
11
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
10.3
11.5
22
23
R50.9
ICD-10 Finland
Fever, unspecified
3.0
11.4
59
229
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
45.2
11.0
13
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.2
10.6
29
74
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
8.7
10.5
22
27
D77
ICPC
Malignant digestive neopl other/NOS
114.0
10.5
11
*
JFB43
NOMESCO Finland
Left hemicolectomy
114.0
10.5
11
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
114.0
10.5
11
*
L01XK01
ATC
olaparib; oral
+∞
10.5
10
*
C48.80
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum without histology
+∞
10.5
10
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
10.5
10
*
WX600
NOMESCO Finland
Single shot through catheter
33.9
10.4
13
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
41.6
10.0
12
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
12.8
10.0
17
14
JFB46
NOMESCO Finland
Resection of sigmoid colon
17.5
10.0
15
9
B03XA02
ATC
darbepoetin alfa; parenteral
17.5
10.0
15
9
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
27.1
9.9
13
5
ZX070
NOMESCO Finland
Intensity modified radiotherapy
103.3
9.5
10
*
XX2RW, ,
NOMESCO Finland
22.6
9.4
13
6
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
9.4
9
*
L01BC06
ATC
capecitabine; oral
+∞
9.4
9
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
9.4
9
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
9.4
9
*
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
9.4
9
*
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
+∞
9.4
9
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
+∞
9.4
9
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
9.3
48
185
R4190
NOMESCO Finland
Nutritional therapy
7.9
9.1
20
27
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
19.4
9.0
13
7
SPAT1109
SPAT
Analgesia with portable analgesic pump
51.6
8.7
10
*
K56.7
ICD-10 Finland
Ileus, unspecified
12.1
8.7
15
13
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
28.5
8.5
11
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
28.5
8.5
11
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
92.7
8.5
9
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
92.7
8.5
9
*
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
92.7
8.5
9
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
4.3
8.4
22
54
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
11.2
8.4
15
14
343
Kela drug reimbursment
Pazopanib
+∞
8.4
8
*
WZC15, ,
NOMESCO Finland
+∞
8.4
8
*
9052/3-C48.2
ICD-O-3
Epithelioid mesothelioma, malignant of peritoneum, NOS
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
8460/3-C48.2
ICD-O-3
Low grade serous carcinoma of peritoneum, NOS
+∞
8.4
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
8.3
121
741
N02AX02
ATC
tramadol; systemic, rectal
2.1
8.3
142
923
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
34.4
8.1
10
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
13.5
8.0
13
10
A02BC02
ATC
pantoprazole; systemic
2.2
7.9
218
1676
C03CA01
ATC
furosemide; systemic
2.0
7.8
116
713
HAB40
NOMESCO Finland
Wedge excision of mammary gland
46.2
7.8
9
*
XX1XW
NOMESCO Finland
Extensive written report from radiologist
8.4
7.7
16
20
R4110
NOMESCO Finland
Physiotherapy
2.1
7.7
89
497
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
12.3
7.7
13
11
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
10.4
7.6
14
14
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.8
7.5
18
28
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.0
7.4
34
123
C49.42
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen liposarcoma
+∞
7.3
7
*
JA3HT
NOMESCO Finland
Tissue sample of abdominal tissue change under UA control
+∞
7.3
7
*
D74
ICPC
Malignant neoplasm stomach
+∞
7.3
7
*
L01EX03
ATC
pazopanib; oral
+∞
7.3
7
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
7.3
7
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
7.3
7
*
C49.43
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen leiomyosarcoma
+∞
7.3
7
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.9
7.2
19
34
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
30.8
7.2
9
*
WX892
NOMESCO Finland
Monitored bed care
3.1
7.0
31
109
SPAT1255
SPAT
Intravenous administration of medicine
3.2
6.8
27
89
S18
ICPC
Laceration/cut
1.9
6.8
150
1042
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
41.0
6.8
8
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.0
6.7
31
112
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
23.1
6.7
9
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.8
6.6
20
55
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
10.4
6.6
12
12
GD1AD
NOMESCO Finland
Thorax CT examination
3.6
6.6
22
65
WW200, ,
SPAT
0.4
6.5
36
759
JFB20
NOMESCO Finland
Ileocaecal resection
71.4
6.5
7
*
WGA11
NOMESCO Finland
Planning of pain management
71.4
6.5
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
71.4
6.5
7
*
TJA10
NOMESCO Finland
Laparocentesis
71.4
6.5
7
*
L02AE02
ATC
leuprorelin; implant, parenteral
71.4
6.5
7
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
6.2
6.4
16
27
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
11.4
6.3
11
10
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
9.6
6.3
12
13
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
JFB50
NOMESCO Finland
Other resection of colon
+∞
6.3
6
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
6.3
6
*
C48.10
ICD-10 Finland
Malignant tumor in specified location in the peritoneum without histology
+∞
6.3
6
*
KKB11
NOMESCO Finland
Percutaneous endoscopic excision of retroperitoneal tumour
+∞
6.3
6
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
6.3
6
*
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C48.22
ICD-10 Finland
Malignant tumor in unspecified localization in peritoneum liposarcoma
+∞
6.3
6
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
6.3
6
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
6.3
6
*
1XC07, ,
NOMESCO Finland
+∞
6.3
6
*
L01CB01
ATC
etoposide; systemic
+∞
6.3
6
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
6.3
6
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.9
6.2
13
17
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.3
6.1
15
25

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
121
55
37.13
174.13
1.5
1.3
—
—
—
0
0
145
134
20.71
148.04
2.6
1.4
2.89
2.66
ug/l
0.26
98
106
72
13
73.43
130.66
1.4
1.0
—
—
—
0
0
78
61
17.14
84.56
2.4
1.7
140.59
13.72
u/ml
0.53
69
48
182
642
5.96
50.18
4.8
3.7
—
—
—
0
0
216
1083
4.94
33.64
4.4
2.3
—
—
estimate
—
0
0
170
719
4.31
33.45
3.7
1.9
—
—
—
0
0
239
1325
5.65
31.85
29.1
6.0
3.97
4.24
e9/l
0.79
207
1144
80
217
4.72
28.04
2.8
2.1
34.93
34.31
u/l
0.04
69
181
138
558
3.82
27.78
3.7
1.9
—
—
—
0
0
74
193
4.81
27.17
2.1
2.1
0.19
0.21
g/l
0.59
65
173
76
203
4.72
27.09
9.1
6.6
—
—
—
0
0
94
300
4.16
26.46
9.9
5.8
0.17
1.54
mmol/l
3.25
81
253
219
1235
4.19
25.94
11.3
14.2
1.16
1.25
inr
2.10
181
1015
94
308
4.04
25.40
10.9
5.7
7.41
7.42
ph
0.22
39
182
101
354
3.85
24.69
1.9
1.8
—
—
—
0
0
65
175
4.50
22.67
1.4
1.1
—
—
—
0
0
158
781
3.26
21.76
2.8
1.7
—
—
—
0
0
154
786
3.05
19.44
6.0
5.0
—
—
—
0
0
142
723
2.90
17.53
3.6
3.0
0.74
0.49
e6/l
0.67
98
540
103
449
3.01
16.80
3.1
2.8
1.03
1.26
e6/l
0.33
51
246
95
400
3.05
16.43
3.1
2.9
4.81
3.17
e6/l
0.65
42
196
74
270
3.34
16.30
11.0
5.9
97.68
94.86
%
7.93
74
263
153
843
2.73
15.77
3.7
3.1
42.18
131.61
e6/l
0.58
111
660
184
1119
2.77
15.47
6.5
5.2
9.23
8.82
%
0.82
175
1044
69
256
3.23
14.67
3.1
2.1
6.81
5.76
umol/l
0.39
63
219
185
1148
2.70
14.61
7.0
5.1
24.37
27.76
%
2.65
177
1082
164
964
2.62
14.41
6.7
3.7
59.69
116.36
e6/l
0.62
116
680
181
1120
2.65
14.24
6.6
5.1
2.19
2.98
%
5.39
174
1040
155
892
2.59
14.16
9.0
2.0
2.35
2.36
mmol/l
0.62
149
772
112
568
2.59
13.11
5.9
2.2
2.52
2.45
mmol/l
5.65
105
509
191
1249
2.56
12.82
6.6
5.0
0.66
0.58
e9/l
2.35
154
1054
178
1131
2.49
12.65
6.8
5.1
59.69
57.41
%
1.18
172
1075
201
1355
2.59
12.50
10.0
5.4
1.18
1.22
mmol/l
7.58
181
1170
177
1126
2.48
12.48
6.7
5.2
0.60
0.67
%
1.23
169
1043
250
1888
3.40
12.38
19.8
5.4
98.09
76.23
u/l
3.78
245
1755
55
198
3.20
12.16
5.9
5.0
8.45
10.06
mmol/l
1.00
55
188
233
1701
2.91
12.11
6.7
4.9
330.50
3185.65
e6/l
—
6
23
190
1260
2.48
12.05
6.6
5.0
0.03
0.04
e9/l
3.67
153
1067
191
1278
2.46
11.74
7.1
5.1
2.03
1.87
e9/l
0.15
155
1107
143
844
2.37
11.71
3.7
2.1
138.26
63.00
u/l
0.46
136
766
192
1304
2.41
11.16
6.9
5.2
0.15
0.20
e9/l
2.15
158
1115
126
726
2.30
10.66
19.3
4.4
—
—
—
0
0
145
893
2.25
10.37
4.1
3.4
—
—
—
0
0
109
597
2.33
10.32
1.5
1.4
—
—
—
0
0
134
803
2.25
10.21
4.7
3.1
7.40
7.40
ph
0.03
103
564
22
30
7.84
9.90
2.8
1.4
2.87
128.79
u/ml
0.50
22
30
14
7
20.92
9.90
1.1
1.0
—
—
—
0
0
15
12
13.11
8.97
2.7
1.3
—
—
—
0
0
16
15
11.21
8.90
2.1
1.0
10602.43
389639.22
e6/l
—
7
9
208
2477
0.43
8.87
4.1
5.5
1.44
1.53
mmol/l
2.53
185
2280
202
2429
0.44
8.68
5.7
7.2
40.02
39.88
mmol/mol
0.09
192
2265
104
593
2.18
8.66
2.8
2.4
9.90
5.80
e6/l
1.56
90
547
64
1147
0.43
8.16
1.6
1.9
1.43
1.30
mmol/l
0.55
51
966
212
2493
0.44
8.14
4.1
5.6
4.66
4.63
mmol/l
0.18
192
2304
15
18
8.72
7.41
2.2
1.0
634.75
2168.62
e6/l
—
8
13
219
2527
0.45
7.23
4.6
6.5
2.71
2.66
mmol/l
0.40
197
2330
155
1081
1.94
7.01
18.4
9.9
0.01
0.00
e9/l
0.66
117
871
13
14
9.66
6.86
1.8
1.0
—
—
—
0
0
47
219
2.37
6.18
2.1
3.6
116.23
236.84
ng/l
2.58
39
203
84
500
1.96
5.90
2.9
2.7
488.14
513.54
mosm/kgh2o
0.60
70
442
87
526
1.94
5.83
3.7
4.4
124.29
311.20
ng/l
0.84
73
422
205
2387
0.51
5.78
5.3
5.8
2.22
1.97
mu/l
1.71
189
2186
11
13
8.74
5.61
2.4
1.0
—
—
—
0
0
203
2365
0.52
5.56
3.7
4.7
1.38
1.28
mmol/l
1.46
178
2149
167
2057
0.55
5.52
4.7
4.6
14.64
14.96
pmol/l
0.90
156
1872
101
660
1.82
5.23
8.1
3.9
—
0.00
—
0
5
218
2474
0.52
5.15
4.9
5.6
6.07
6.00
mmol/l
0.31
203
2258
23
538
0.38
5.07
1.0
1.3
8.20
34.76
iu/ml
—
5
157
180
1398
1.76
5.06
7.8
4.1
0.00
0.00
estimate
0.50
39
263
53
284
2.06
4.93
2.7
2.9
1.48
2.33
mmol/l
0.98
45
248
89
569
1.82
4.90
2.2
1.6
1.76
1.19
mg/l
2.13
80
456
13
28
4.81
4.42
4.4
2.5
4.82
4.29
e9/l
0.31
13
28
15
39
4.00
4.26
3.6
2.3
7.95
180.65
u/l
—
6
13
10
17
6.05
4.16
1.1
1.2
—
—
—
0
0
15
47
3.31
4.12
3.2
3.6
3.42
2.93
mmol/l
—
9
31
147
1120
1.64
4.10
7.3
3.6
6.28
6.28
ph
0.02
82
627
97
668
1.68
4.00
2.1
2.2
2.35
2.94
mg/l
1.72
84
567
24
499
0.43
3.90
1.1
1.3
21.94
12.82
u/ml
—
7
180
43
233
1.99
3.86
1.4
1.9
54.43
66.32
e9/l
1.28
20
180
51
294
1.89
3.83
2.8
3.0
7.39
7.39
ph
0.10
28
182
7
8
8.93
3.79
1.3
1.0
—
—
—
0
0
32
156
2.18
3.78
5.8
4.1
—
—
—
0
0
170
1376
1.57
3.45
8.0
4.0
0.00
0.00
estimate
-0.00
38
273
76
515
1.65
3.26
5.3
3.7
—
—
—
0
0
54
335
1.75
3.19
5.0
3.8
1.11
1.01
mmol/l
1.36
54
300
13
40
3.35
3.18
4.6
2.1
60.31
58.07
%
0.26
13
40
170
1393
1.54
3.14
8.0
4.0
0.00
0.00
estimate
-0.00
37
277
10
25
4.10
3.11
1.0
1.3
—
—
—
0
0
62
899
0.60
3.08
2.8
3.6
—
—
—
0
0
34
185
1.95
3.03
8.3
3.4
—
—
—
0
0
17
69
2.56
3.02
12.3
5.1
1.57
1.34
mmol/l
0.41
17
63
17
70
2.52
2.94
3.1
1.8
—
—
—
0
0
9
23
4.00
2.80
1.0
1.2
—
—
—
0
0
32
177
1.91
2.73
11.8
5.6
24.27
24.77
mmol/l
0.51
32
172
8
20
4.08
2.58
2.0
1.8
—
—
—
0
0
7
16
4.46
2.49
1.0
1.7
11.03
11.15
%
—
7
16
77
1017
0.67
2.36
3.8
4.1
12.13
7.00
mg/mmol
0.58
48
608
25
135
1.93
2.30
1.1
1.3
—
—
—
0
0
6
167
0.35
2.22
1.0
1.2
542.45
322.79
u/ml
—
6
155
20
102
2.03
2.16
5.4
1.8
577.85
745.10
ug/l
0.14
20
97
40
255
1.66
2.15
1.3
1.5
—
—
—
0
0
7
172
0.39
1.98
1.4
1.4
—
—
—
0
0
10
39
2.62
1.96
2.7
1.2
—
—
nmol/l
—
0
0
219
1977
1.44
1.93
51.3
17.3
14.81
13.62
%
18.78
219
1953
30
183
1.71
1.91
2.0
2.6
112.30
130.50
g/l
4.92
30
178
11
46
2.45
1.87
1.5
2.7
—
—
—
0
0
79
1003
0.71
1.85
2.9
3.4
65.33
41.22
mg/l
0.41
48
612
6
17
3.58
1.84
1.0
1.4
—
—
—
0
0
26
154
1.76
1.83
1.8
2.3
1.25
1.12
%
0.37
26
154
7
23
3.09
1.81
1.6
3.3
—
—
—
0
0
8
30
2.71
1.73
1.4
1.8
92.39
90.24
%
—
8
30
5
13
3.89
1.72
4.4
1.8
0.60
0.92
index
—
5
13
259
2435
1.61
1.71
35.5
14.0
47.13
22.92
mg/l
15.94
252
1987
25
151
1.72
1.66
1.8
2.3
0.58
0.61
%
0.16
25
151
7
25
2.84
1.66
2.6
2.8
—
—
—
0
0
32
207
1.61
1.65
1.2
1.5
—
—
—
0
0
29
183
1.65
1.65
3.3
3.5
1.22
0.41
%
1.66
18
34
5
14
3.61
1.62
1.4
3.8
—
—
—
0
0
21
122
1.78
1.59
1.2
1.3
—
—
—
0
0
83
1023
0.74
1.56
2.8
3.3
6.07
6.97
mmol/l
1.24
66
852
31
202
1.60
1.56
6.3
2.8
1.24
1.23
mmol/l
0.33
31
171
5
121
0.40
1.41
1.0
1.0
—
—
—
0
0
29
195
1.54
1.30
3.4
3.5
1.33
0.78
%
0.74
18
38
39
280
1.45
1.29
1.8
1.7
—
—
—
0
0
13
223
0.56
1.21
1.9
1.5
—
—
—
0
0
8
148
0.53
1.07
2.0
2.1
—
—
—
0
0
27
189
1.47
1.03
3.6
3.6
0.25
0.06
%
0.64
16
32
79
658
1.28
1.03
2.8
2.2
338.94
344.92
umol/l
0.18
71
563
172
1567
1.24
1.02
4.6
3.2
62.60
44.03
u/l
1.04
158
1456
7
132
0.52
1.01
1.4
1.6
—
—
—
0
0
0
30
0.00
0.98
0.0
1.7
—
—
—
0
0
0
32
0.00
0.95
0.0
2.8
—
—
—
0
0
40
510
0.75
0.92
1.7
1.7
1126.95
1183.16
nmol/l
0.15
32
386
115
1292
0.82
0.91
2.0
2.2
86.70
96.74
pmol/l
1.60
63
613
85
725
1.24
0.91
5.7
3.4
0.06
0.00
estimate
0.49
36
218
7
126
0.54
0.90
1.0
1.6
—
6.39
—
0
30
27
195
1.42
0.90
3.6
3.7
0.07
0.00
%
0.48
15
29
6
29
2.09
0.90
1.3
1.3
—
—
—
0
0
104
913
1.22
0.84
3.2
3.2
1807.19
1347.14
ng/l
0.47
94
773
90
782
1.22
0.80
8.0
4.0
0.00
0.00
estimate
-0.00
39
253
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
128
1153
1.20
0.78
2.5
2.9
219.18
108.48
ug/l
3.73
122
1071
10
161
0.61
0.78
1.3
1.4
—
—
—
0
0
117
1049
1.19
0.75
6.6
3.9
0.00
0.01
estimate
0.50
33
217
6
110
0.54
0.73
1.7
1.2
—
—
—
0
0
5
26
1.94
0.71
4.6
2.2
19.40
11.85
index
—
5
13
20
145
1.41
0.68
2.2
2.6
25.82
25.54
mmol/l
0.18
20
139
40
325
1.27
0.65
1.6
1.5
—
—
—
0
0
6
104
0.57
0.63
1.2
1.2
—
0.24
—
0
8
0
20
0.00
0.60
0.0
1.5
—
514813.92
—
0
13
26
203
1.31
0.58
1.2
1.2
—
—
—
0
0
8
54
1.49
0.57
1.0
1.4
1.27
0.89
nmol/l
—
8
43
6
40
1.51
0.52
1.0
1.2
—
—
—
0
0
7
49
1.44
0.46
1.0
1.4
—
—
—
0
0
10
69
1.47
0.45
1.3
1.2
—
—
—
0
0
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
53
598
0.86
0.41
1.3
1.3
0.79
1.56
u/ml
1.12
15
176
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.41
0.0
1.3
—
30.00
—
0
11
261
2657
0.82
0.40
60.2
21.8
119.98
134.27
g/l
37.13
256
2616
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
261
2656
0.82
0.39
59.4
21.6
91.75
91.30
fl
0.70
256
2616
261
2656
0.82
0.39
59.3
21.5
30.16
30.30
pg
0.52
256
2616
261
2656
0.82
0.39
61.2
21.9
36.61
40.10
%
28.43
256
2615
261
2656
0.82
0.39
59.6
21.7
7.21
6.65
e9/l
1.16
251
2580
261
2656
0.82
0.39
60.0
21.6
269.98
250.67
e9/l
3.17
251
2593
261
2656
0.82
0.39
59.5
21.6
4.10
4.46
e12/l
20.21
250
2582
45
395
1.16
0.38
1.1
1.2
—
—
—
0
0
11
146
0.74
0.37
2.5
2.5
—
—
—
0
0
6
41
1.47
0.36
4.7
1.8
11.00
10.49
mmol/l
—
6
41
22
265
0.82
0.36
1.4
1.6
—
—
—
0
0
13
100
1.31
0.34
2.5
1.4
12.80
10.96
g/l
0.33
13
88
6
87
0.68
0.33
1.2
1.1
—
—
—
0
0
6
88
0.68
0.33
1.0
1.9
—
—
—
0
0
32
363
0.87
0.28
1.2
1.3
457.14
605.42
titre
—
7
96
8
63
1.28
0.28
1.4
1.2
—
—
—
0
0
260
2561
1.15
0.26
45.0
17.7
138.43
139.87
mmol/l
12.44
254
2504
7
92
0.76
0.23
2.9
1.4
45.39
43.32
mg/l
—
7
84
7
92
0.76
0.23
2.9
1.4
32.87
31.44
mg/l
—
7
84
260
2565
1.14
0.22
45.0
17.8
3.98
3.98
mmol/l
0.07
254
2500
0
11
0.00
0.21
0.0
4.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
108.59
—
0
11
0
10
0.00
0.21
0.0
1.1
—
5.92
—
0
10
0
13
0.00
0.21
0.0
1.5
—
7.54
—
0
7
18
208
0.86
0.21
2.2
2.8
5.85
6.01
ph
0.34
13
146
13
155
0.83
0.20
3.8
3.7
1.02
1.02
ratio
0.29
13
145
0
14
0.00
0.20
0.0
1.1
—
39.94
—
0
8
6
49
1.23
0.20
1.3
1.1
—
—
—
0
0
6
50
1.20
0.20
1.0
1.2
—
—
—
0
0
81
852
0.93
0.19
1.7
1.7
19.33
20.94
nmol/l
0.59
75
719
10
82
1.23
0.17
1.3
1.2
—
—
—
0
0
6
79
0.75
0.15
3.3
4.4
—
—
—
0
0
114
1102
1.06
0.15
3.6
4.0
59.25
110.98
ng/l
0.38
92
830
8
99
0.80
0.14
1.1
1.2
—
—
—
0
0
66
634
1.05
0.11
6.5
4.3
1.02
1.02
kg/l
0.00
53
419
17
187
0.90
0.10
1.2
1.3
—
—
—
0
0
29
274
1.06
0.08
1.3
1.3
—
—
—
0
0
8
76
1.05
0.07
3.4
4.3
23.60
25.30
mmol/l
—
8
71
32
304
1.06
0.07
1.5
1.7
—
—
—
0
0
31
325
0.95
0.06
2.0
2.0
99.35
147.70
ug/g
0.71
25
258
259
2604
0.95
0.06
28.0
10.4
25.20
24.13
u/l
0.55
252
2499
56
544
1.04
0.06
4.0
4.2
1.56
2.03
ug/l
1.13
48
492
47
485
0.96
0.05
2.1
1.3
2.28
2.59
g/l
0.63
30
275
59
604
0.97
0.04
1.8
1.8
487.11
23926832.65
pmol/l
0.50
46
489
26
271
0.96
0.04
3.2
2.1
0.00
0.00
estimate
—
6
53
261
2619
0.96
0.02
52.2
19.1
79.52
76.37
umol/l
1.06
256
2576
11
104
1.06
0.01
3.3
3.6
—
—
—
0
0
13
126
1.03
0.00
1.0
1.1
—
—
—
0
0
251
2514
0.99
0.00
28.6
13.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.5
—
5.00
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
78.60
—
0
5
0
8
0.00
-0.00
0.0
6.4
—
26.00
—
0
8
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
5.6
—
7.83
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
0.00
—
0
6
0
6
0.00
-0.00
0.0
2.7
—
6.50
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
24.14
—
0
7
5
56
0.89
-0.00
1.2
2.0
3.57
5.19
mmol/24h
—
5
50
0
5
0.00
-0.00
0.0
4.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
67
0.89
-0.00
2.7
2.3
8.85
12.69
mg/l
—
6
62
0
9
0.00
-0.00
0.0
5.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
10.76
—
0
7
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: C3_RETROPERITONEUM_PERITONEUM – Malignant neoplasm of retroperitoneum and peritoneum

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).